# Pluripotent stem cell-derived extracellular vesicles for systemic immune modulation in diabetes therapy

Source: [nature.com](https://www.nature.com/articles/s41565-026-02320-z) · 2026-11-18 · Physics
Page: https://themorning.science/story/pluripotent-stem-cell-derived-extracellular-vesicles-for-systemic-immune-modulat-14caa2d0f4e0e058
Kind: research · Impact: medium

## In brief

- Two papers published online in Nature Nanotechnology on 18 November 2026 report that pluripotent stem cells secrete extracellular vesicles with unique molecular signatures and immunomodulatory activity.
- The second paper reports that these vesicles induce immune tolerance and can be produced at scale in suspension culture.
- The second paper also reports delivery from an injectable hydrogel in the context of diabetes therapy; the source excerpt is cut off before stating the protective outcome.

## Why it matters

The work suggests a cell-free approach to immune tolerance that could be relevant to diabetes therapy, and its scalable production and injectable delivery are the practical points for researchers to evaluate.

## Timeline

- 2026-11-18: Two papers published online in Nature Nanotechnology

## Coverage

- [A pluripotent source of immune tolerance](https://www.nature.com/articles/s41565-026-02291-1) — nature.com, 2026-11-18
- [Pluripotent stem cell-derived extracellular vesicles for systemic immune modulation in diabetes therapy](https://www.nature.com/articles/s41565-026-02320-z) — nature.com, 2026-11-18

Tags: extracellular vesicles, immune tolerance, diabetes, stem cells, nanomedicine

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
